I personally don't plan to buy more shares on anticipation of a buyout until May 30-31. Lots could change before then. If a financing, I'll wait for the bottom. And if they finance $1 million at a time, I'll personally just invest elsewhere.
You think management would take on another FDA trial and increase their cash burn rate when they can not even pay for what they currently have going? Does not add up. I know BO/merger is unpopular with you because it admittedly is often just a pipe dream scenario. But considering the actions of the company lately it is defiantly not business as usual. Could be an attempt to land a better offering but still everything together does not make since.
1) Management raised their salary's and promoted Barbera Keck to CFO in the middle of the SP freefall. A move they knew would be unpopular but they needed to get her in as CFO in order to protect her and wanted to adjust their pay scales before making up their Golden Parachute severance packages.
2) Started a new FDA trial. When they cant even pay for the one they have now. But would be seen as a value.
3) Started doing PR! What? Not just SEC filings but real words that sound positive. (For most company's a given but unheard of in recent Delcath history)
Now are those actions anything close to what this company has done for any other previous offering? No.
News 
Market Data 
Discover 
